Anti-NM LPDA

Y123230 by Applied Biological Materials Inc. (ABM) is a mouse monoclonal IgG2b antibody targeting fragment (aa/332-469) of Neisseria meningitidis LpdA (NM LPDA), validated for Western blot at 1:1000 and for ELISA. Affinity purified, 100 µg/100 µl in citrate-tris-HCl buffer (pH 7.0). MBP is a registered vendor for Howard Hughes Medical Institute, Vanderbilt University, MD Anderson Cancer Center, and Eurofins, among other leading institutes across the USA.